Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Aug;14(Supplement 1):10-5.

Effects of treatment on the overall functioning of children with ADHD

Lily Hechtman  1
Affiliations

Effects of treatment on the overall functioning of children with ADHD

Lily Hechtman. Can Child Adolesc Psychiatr Rev. 2005 Aug.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
CON-CAN-1: Primary effectiveness results Steele M, et al. Presented at the APA Annual Meeting; May 1–6, 2004; New York, NY.
Figure 2
Figure 2
Mean Parental Stress Index (PSI) scores Steele M, et al. Presented at the APA Annual Meeting; May 1–6, 2004; New York, NY.
Figure 3
Figure 3
Mean change in total score on Visual Analogue Scale (VAS) for social play Steele M, et al. Presented at the APA Annual Meeting; May 1–6, 2004; New York, NY.
Figure 4
Figure 4
CON-CAN-1: Other key outcome measures Steele M, et al. Presented at the APA Annual Meeting; May 1–6, 2004; New York, NY.
Figure 5
Figure 5
OROS-MPH vs IR-MPH: Remission rates Greenhill LL, et al. Presented at the APA Annual Meeting; May 1–6, 2004; New York, NY.
Figure 6
Figure 6
OROS-MPH demonstrated lower impaired driving scores Participants performed significantly better when receiving OROS-MPH qd compared with MPH tid. Cox DJ, et al. Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: a pilot study. J Am Acad Child Adolesc Psychiatry 2004;43:269 Changes in impaired driving scores over the course of the study. Lower score denotes better driving performance. MPH – methylphenidate.
Figure 7
Figure 7
Clinician (CGI) and Parent (PGA) Global Improvement Ratings at study endpoint Reproduced with permission from Pediatrics, Vol. 110, Pages 258–266. Copyright © 2002 by the AAP. Investigator (CGI) and parent (PGA) global improvement ratings at study endpoint. All comparisons to placebo significant (p < 0.001).
See this image and copyright information in PMC

References

    1. Steele M, Riccardelli R, Binder C. Effectiveness of OROS-methylphenidate vs usual care with immediate-release methylphenidate in ADHD children. Presented at the American Psychiatric Association Annual Meeting; May 1–6, 2004; New York, NY.
    1. Swanson J. School-based Assessments and Interventions for ADD Students. Irvine, California: KC Publications; 1992. Available at www.adhd.net Accessed October 27, 2004.
    1. Greenhill LL, Wan G, Cooper KM. Remission of ADHD symptoms with stimulant therapy. Poster presented at the American Psychiatric Association; May 1–6, 2004; New York, NY.
    1. Cox DJ, Merkel RL, Kovatchev B, Seward R. Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial. J Nerv Ment Dis. 2000;188:230–234. - PubMed
    1. Cox DJ, Merkel RL, Penberthy JK, Kovatchev B, Hankin CS. Impact of methylphenidate delivery profiles on driving performance of adolescents with attention deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2004;43:269–275. - PubMed

LinkOut - more resources